|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 120 out of 120 for Tigit

<< First    < Previous  |  Next >    Last >>
0.017s
Type Details Score
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tigit/Tigit<+>
Background: involves: 129S6/SvEvTac * C57BL/6NCrl
Zygosity: cn
Has Mutant Allele: true
Publication
First Author: Zhu Y
Year: 2016
Journal: J Exp Med
Title: Identification of CD112R as a novel checkpoint for human T cells.
Volume: 213
Issue: 2
Pages: 167-76
Publication
First Author: Guan X
Year: 2024
Journal: Nature
Title: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and T(reg) cells.
Volume: 627
Issue: 8004
Pages: 646-655
Publication
First Author: Botta C
Year: 2023
Journal: Nat Commun
Title: Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance.
Volume: 14
Issue: 1
Pages: 5825
Publication  
First Author: Serr I
Year: 2016
Journal: Nat Commun
Title: Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
Volume: 7
Pages: 10991
Publication
First Author: Zhu F
Year: 2023
Journal: Nat Commun
Title: Spatiotemporal resolution of germinal center Tfh cell differentiation and divergence from central memory CD4(+) T cell fate.
Volume: 14
Issue: 1
Pages: 3611
Publication  
First Author: Downs-Canner S
Year: 2017
Journal: Nat Commun
Title: Suppressive IL-17A+Foxp3+ and ex-Th17 IL-17AnegFoxp3+ Treg cells are a source of tumour-associated Treg cells.
Volume: 8
Pages: 14649
Publication
First Author: Wienke J
Year: 2024
Journal: Cancer Cell
Title: Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy.
Volume: 42
Issue: 2
Pages: 283-300.e8
Publication  
First Author: Okumura G
Year: 2020
Journal: J Exp Med
Title: Tumor-derived soluble CD155 inhibits DNAM-1-mediated antitumor activity of natural killer cells.
Volume: 217
Issue: 4
Publication
First Author: Alteber Z
Year: 2021
Journal: Cancer Discov
Title: Therapeutic Targeting of Checkpoint Receptors within the DNAM1 Axis.
Volume: 11
Issue: 5
Pages: 1040-1051
Publication
First Author: Luci C
Year: 2021
Journal: J Invest Dermatol
Title: Cutaneous Squamous Cell Carcinoma Development Is Associated with a Temporal Infiltration of ILC1 and NK Cells with Immune Dysfunctions.
Volume: 141
Issue: 10
Pages: 2369-2379
Publication
First Author: Lenac Rovis T
Year: 2016
Journal: J Exp Med
Title: Inflammatory monocytes and NK cells play a crucial role in DNAM-1-dependent control of cytomegalovirus infection.
Volume: 213
Issue: 9
Pages: 1835-50
Publication
First Author: Yang J
Year: 2024
Journal: Cancer Immunol Res
Title: PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways.
Volume: 12
Issue: 5
Pages: 575-591
Publication
First Author: Lahmann A
Year: 2019
Journal: J Immunol
Title: Bach2 Controls T Follicular Helper Cells by Direct Repression of Bcl-6.
Volume: 202
Issue: 8
Pages: 2229-2239
Publication  
First Author: O'Donnell JS
Year: 2020
Journal: Semin Cancer Biol
Title: Tumor intrinsic and extrinsic immune functions of CD155.
Volume: 65
Pages: 189-196
Publication
First Author: Chiang EY
Year: 2020
Journal: Eur J Immunol
Title: CD96 functions as a co-stimulatory receptor to enhance CD8+ T cell activation and effector responses.
Volume: 50
Issue: 6
Pages: 891-902
Publication
First Author: Bod L
Year: 2023
Journal: Nature
Title: B-cell-specific checkpoint molecules that regulate anti-tumour immunity.
Volume: 619
Issue: 7969
Pages: 348-356
Publication  
First Author: Kawashima S
Year: 2021
Journal: J Immunother Cancer
Title: TIGIT/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironment.
Volume: 9
Issue: 11
Publication
First Author: Yasuma K
Year: 2016
Journal: PLoS Pathog
Title: HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).
Volume: 12
Issue: 1
Pages: e1005372
Publication  
First Author: Felix KM
Year: 2019
Journal: Front Immunol
Title: P2RX7 Deletion in T Cells Promotes Autoimmune Arthritis by Unleashing the Tfh Cell Response.
Volume: 10
Pages: 411